COMPULSORY LICENSING AS A TOOL FOR GLOBAL PUBLIC INTEREST: EVOLUTION, CHALLENGES, AND REFORM
Ключевые слова:
Keywords: Compulsory Licensing; TRIPS Agreement; Doha Declaration; Intellectual Property; Public Health; Access to Medicines; Sustainable Development; Innovation Equity; Green Technologies; Digital Access; Food Security; WTO; WIPO.Аннотация
This paper explores the evolving role of compulsory licensing (CL) as a critical legal and policy tool for reconciling intellectual property rights with the broader public interest in the 21st century. While the TRIPS Agreement and the Doha Declaration provide member states with considerable flexibility to issue CLs in situations of national emergency and public need, practical obstacles—including procedural complexity, vague legal definitions, and geopolitical pressures—continue to limit its application. Drawing on historical development, international legal frameworks, and recent case studies, this study examines the potential of CL not only in the context of public health, but also in addressing global challenges such as climate change, digital inequality, and food insecurity. The conclusion outlines specific legal, institutional, and policy reforms at national and international levels aimed at making CL more effective, equitable, and responsive to emerging societal needs. By reframing CL as a mechanism of innovation equity, the paper argues for a renewed commitment to cooperative global governance in the management and dissemination of patented knowledge.
Библиографические ссылки
1. Abbott, F.M., 2005. The WTO medicines decision: world pharmaceutical trade and the protection of public health. American Journal of International Law, 99(2), pp.317–358.
2. Correa, C.M., 2002. Implications of the Doha Declaration on the TRIPS Agreement and Public Health. Geneva: World Health Organization.
3. Kienzle, B., 2014. Compulsory licensing in the pharmaceutical sector: a global perspective of the tension between IP rights and public health needs. Journal of Intellectual Property Law & Practice, 9(12), pp.1011–1020.
4. Love, J., 2007. Remuneration Guidelines for Non-Voluntary Use of a Patent on Medical Technologies. Geneva: World Health Organization/UNDP.
5. UNCTAD. (2022). Compulsory licensing practices and policies: Global overview. [Electronic resource]. Retrieved from https://unctad.org
6. World Health Organization (WHO). (2021). COVID-19 Technology Access Pool (C-TAP). Geneva: WHO.
7. Pugach, M. P. (2021). Compulsory licensing in the pandemic era: policy shifts and global implications. Innovation Files;
8. President of the Republic of Uzbekistan. (2022, April 26). On additional measures for the further development of the field of intellectual property, Decree No. PP–221. [Electronic resource]. Retrieved from https://lex.uz/docs/5987120
9. Government of Uzbekistan. (2022). New Uzbekistan Development Strategy for 2022–2026. [Electronic resource]. Retrieved from https://lex.uz/docs/5841063
10. Yakubova, I. B. (2021). International intellectual property law: A textbook. Tashkent: Tashkent State University of Law Publishing House.
11. 't Hoen, E.F.M., 2016. Private Patents and Public Health: Changing Intellectual Property Rules for Access to Medicines. Amsterdam: Health Action International.
12. UNCTAD, 2015. Investment Policy Framework for Sustainable Development. Geneva: United Nations Conference on Trade and Development.
13. WIPO, 2019. WIPO GREEN Strategic Plan: Promoting Innovation and Diffusion of Green Technologies. Geneva: World Intellectual Property Organization.
14. WIPO, 2020. Patent-Related Flexibilities in the Multilateral Legal Framework and Their Legislative Implementation at the National and Regional Levels. Geneva: WIPO.
15. World Health Organization, 2021. Guidelines on Country Use of TRIPS Flexibilities for Public Health Purposes. Geneva: WHO.
16. World Trade Organization, 1994. Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS). Geneva: WTO.
17. World Trade Organization, 2001. Declaration on the TRIPS Agreement and Public Health (Doha Declaration). WT/MIN(01)/DEC/2. Geneva: WTO.
18. Yu, P.K., 2009. The objectives and principles of the TRIPS Agreement. Houston Law Review, 46(4), pp.979–1046.
